CLNE vs CLOV

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 21, 2026

CLNE

55.8
AI Score
VS
CLNE Wins

CLOV

51.4
AI Score

Investment Advisor Scores

CLNE

56score
Recommendation
HOLD

CLOV

51score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric CLNE CLOV Winner
Forward P/E 6.8966 37.7358 CLNE
PEG Ratio 4.7217 0 Tie
Revenue Growth 3.7% 55.6% CLOV
Earnings Growth 512.0% 0.0% CLNE
Tradestie Score 55.8/100 51.4/100 CLNE
Profit Margin -21.3% -0.7% CLOV
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

CLNE 1M: -13.6% · 3M: -31.0% CLOV 1M: +3.5% · 3M: +9.5%

Current Technical Phase

CLNE

Markdown
Sell / avoid

Price below a falling SMA50 (slope -10.4%), weak momentum, RSI 40

RSI (14): 39.7 · Price: $1.40

CLOV

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (1.2% over 20 days), RSI 55

RSI (14): 54.9 · Price: $4.73

Fundamentals Snapshot

Metric CLNE CLOV
Market Cap — —
Forward P/E -32.9 31.5
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.0% 0.6%
Gross Margin 0.3% 0.2%
Operating Margin 0.0% 0.0%
EPS -0.43 -0.05
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, CLNE is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.